| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:1202.)
© 2003 American Heart Association, Inc.
Basic Science Reports |
From the Laboratory of Pneumology, Unit of Lung Toxicology (A.N., P.H.M.H., B.N.), and Center for Molecular and Vascular Biology (J.V., M.F.H.), Kapholieke Universiteit Leuven, Leuven, Belgium, and Medical Research Council Toxicology Unit (D.D.), Leicester, United Kingdom.
Correspondence to Prof B. Nemery, K.U. Leuven, Laboratory of Pneumology, Unit of Lung Toxicology, Herestraat, 49 B-3000, Leuven, Belgium. E-mail ben.nemery{at}med.kuleuven.ac.be
| Abstract |
|---|
|
|
|---|
Methods and Results Diesel exhaust particles (DEPs) were instilled into the trachea of hamsters, and blood platelet activation, experimental thrombosis, and lung inflammation were studied. Doses of 5 to 500 µg of DEPs per animal induced neutrophil influx into the bronchoalveolar lavage fluid with elevation of protein and histamine but without lactate dehydrogenase release. The same doses enhanced experimental arterial and venous platelet rich-thrombus formation in vivo. Blood samples taken from hamsters 30 and 60 minutes after instillation of 50 µg of DEPs yielded accelerated aperture closure (ie, platelet activation) ex vivo, when analyzed in the Platelet Function Analyser (PFA-100). The direct addition of as little as 0.5 µg/mL DEPs to untreated hamster blood significantly shortened closure time in vitro.
Conclusions The intratracheal instillation of DEPs leads to lung inflammation as well as a rapid activation of circulating blood platelets. The kinetics of platelet activation are consistent with the reported clinical occurrence of thrombotic complications after exposure to pollutants. Our findings, therefore, provide a plausible explanation for the increase in cardiovascular morbidity and mortality accompanying urban air pollution.
Key Words: thrombosis lung inflammation air pollution
| Introduction |
|---|
|
|
|---|
Studies suggest that fine particles with a diameter <2.5 µm (PM2.5) have an important role in triggering biological responses.1,6 These particles, and particularly the ultrafine fraction (<100 nm), remain airborne for long periods of time7; penetrate deeply into the respiratory tract; and can carry large amounts of toxic compounds, such as hydrocarbons and metals, on their surfaces.8
In urban areas, diesel engines are considered to be the major source of PM2.5. Salvi et al9,10 reported that short-term exposure of humans to diesel exhaust particles (DEPs) induces inflammatory responses not only in the airways but also in the peripheral blood. In vitro, DEPs are taken up by airway epithelial cells and stimulate the release of proinflammatory cytokines.11
Myocardial infarction results from rupture of an atherosclerotic plaque in the coronary artery, followed by rapid thrombus growth as a consequence of exposure of highly reactive subendothelial structures to circulating blood, thus leading to additional or complete obstruction of the blood vessel.12 Thromboembolic disease is a major cause of morbidity and mortality in the elderly, ie, the fraction of the population that is most susceptible to the adverse effects of air pollution.13 Recently, Peters et al6 have shown that exposure to PM2.5 for as little as 2 hours increases the risk of myocardial infarction.
We have shown that ultrafine particles (UFPs) diffuse rapidly, ie, within 1 hour, from the lungs into the systemic circulation in hamsters14 and in humans.15 We have also demonstrated that intravenously and intratracheally administered positively charged polystyrene particles enhance experimental thrombosis in hamsters, a phenomenon demonstrated to result from particle-facilitated blood platelet activation.16,17
We have now extended these studies to relevant pollutant particles, ie, DEPs, to investigate further the epidemiological association between particulate air pollution and cardiovascular morbidity and mortality. The intratracheal instillation of DEPs in hamsters not only leads to the rapid induction of pulmonary inflammation but also enhances both arterial and venous thrombosis after minor vessel injury, in association with circulating platelet activation.
| Methods |
|---|
|
|
|---|
For electron microscopy, droplets (10 µL) of a suspension of 1 mg of DEPs in 500 µL were placed on matured formvar/carbon film for 30 seconds. The samples were then drained and inverted onto droplets of ultrapure water for 1 hour before being drained, dried, and examined in a Zeiss 902A electron microscope. Further samples were examined, using a dialyzed suspension or films wetted with bacitracin, and produced similar results.
Experimental Arterial and Venous Thrombosis Model
This study was reviewed and approved by the Institutional Review Board of the University of Leuven, and experiments were performed in accordance with protocols approved by the Institutional Animal Care and Research Advisory Committee.
The technique used to induce and monitor mural thrombosis has been described.18 Male and female hamsters (Pfd Gold, University of Leuven, Belgium) weighing 100 to 110 g were anesthetized with sodium pentobarbital (60 mg/kg, ip.). The animals were placed in a supine position on a heating pad (37°C). A 2F venous catheter (Portex) was inserted in the right jugular vein, and the right femoral vein or artery was exposed and mounted on a transilluminator. The tracheal zone was shaved and disinfected with ethanol (70%), and the trachea was exposed for the intratracheal administration of 120 µL of vehicle or DEPs (5, 50, or 500 µg per animal). Ten minutes later, Rose Bengal (Sigma) was administered in the jugular vein (20 mg/kg body weight), and the exposed segment of femoral vein or artery was irradiated, for 2 or 1.5 minutes, respectively, with green light (wavelength 540 nm) using a xenon lamp (L4887, Hamamatsu Photonics) equipped with a heat-absorbing filter and green filter. This protocol produced mild but measurable thrombosis induction.
The formation and embolization of the thrombus were continuously monitored for 40 minutes under a microscope at 40 times magnification. The change over time of light transmission through the blood vessel at the site of the vascular injury was recorded through a microscope-attached camera. Images were recorded at 10-second intervals. Image analysis (Optimas, 6.5) was used to quantify thrombus intensity and calculate the kinetics of thrombus formation. Thrombus size was expressed in arbitrary units as the total area under the curve, when the light intensity is plotted against time. Light intensity is proportional to the thrombus size intensity (rich in colorless platelets) and is expressed as the product between the number of pixels selected in the thrombus area and the mean light intensity for all pixels selected (Figure 1). The animals were euthanized at the end of the recording.
|
Bronchoalveolar Lavage Fluid Analysis
In separate experiments, 1 hour after intratracheal instillation of DEPs (0, 5, 50, or 500 µg per animal), animals were killed with an overdose of sodium pentobarbital. Bronchoalveolar lavage (BAL) was performed by cannulating the trachea and lavaging the lungs with sterile saline (3x1.5 mL). The recovered fluid aliquots were pooled and centrifuged (1000g for 10 minutes, 4°C). Cells were counted in a Thoma hemocytometer after resuspension of the pellets and staining with 1% gentian violet. Cells were differentiated on cytocentrifuge preparations fixed in methanol and stained with Diff Quick (Dade).
In supernatants, lactate dehydrogenase (LDH) activities were determined on fresh samples using standard clinical laboratory methods, whereas total protein (Biorad München) and histamine concentrations (radioimmunoassay kit, Immunotech) were measured after storage at -20°C.
Platelet Function Analysis
Ex Vivo
Hamsters were anesthetized and intratracheally instilled with DEPs (0 or 50 µg per animal) as described above. Five, 15, 30, and 60 minutes later, venous blood was collected from the abdominal vena cava on hirudin (20 µg/mL) and supplemented with 0.4% citrate. Platelets were counted (Cell Dyn 1300, Abbott), and platelet function was assessed in the Platelet Function Analyser PFA-100 (Dade-Behring, Marburg, Germany).19 The PFA-100 test cartridge consists of a capillary, a blood sample reservoir, and a membrane coated with collagen/epinephrine with a central aperture. Blood is aspirated through the capillary and the aperture thus exposing platelets to high shear rates (5000/second), causing platelet activation. A platelet thrombus forms at the aperture, thus gradually diminishing and finally arresting blood flow. The time from the start of aspiration until the aperture completely occludes, ie, the closure time, reflects platelet aggregation in a shear stressdependent way.19
In Vitro
Saline or saline containing DEPs (0.1, 0.5, 1, and 5 µg/mL) was added to venous blood from untreated hamsters, and closure time was measured in the PFA-100 after 5 minutes.
Statistics
For all experiments at least one saline-treated animal was studied every day. Data are expressed as mean±SEM. Comparisons between groups were performed by one-way ANOVA, followed by the Dunnett multiple-range test or unpaired Student t test. Probability values <0.05 are considered significant.
| Results |
|---|
|
|
|---|
|
In control hamsters there were only
300 polymorphonuclear neutrophils (PMNs) per milliliter BAL fluid (1% of 32,300 total cells/mL), the remaining cells being macrophages. Intratracheal instillation of DEPs resulted in a marked cellular influx at all three doses. Mean total cell numbers in BAL increased to 862 000, 873 000, and 977 000 cells/mL at 5, 50, and 500 µg per animal, respectively. Figure 3a shows that PMN numbers were increased, on average, to
100 000 cells/mL (10 to 12% of total cells), thus implying that macrophage numbers were also increased. This was accompanied by dose-dependent increases in BAL protein (Figure 3b) and histamine concentrations (Figure 3c), without significant changes in LDH (Figure 3d).
|
Figures 4a and 4b illustrate that the intratracheal instillation of DEPs induced an increase in the cumulative mass of thrombus formed in vivo over a 40-minute interval in a photochemically injured vessel. DEPs induced a dose-dependent enhancement of (platelet-rich) venous thrombus generation at a dose of only 5 µg per animal (+235%), and at 50 µg per animal (+503%, P<0.05) and 500 µg per animal (+720%, P<0.01) (Figure 4a). Similarly, DEPs significantly increased arterial thrombus formation at 50 µg per animal (+278%, P=0.01) (Figure 4b). The inserted frames show representative pictures of the segment of femoral vein (Figure 4a) or femoral artery (Figure 4b). The white sections represent the intravascular thrombus attached to the subendothelium. The arterial thrombus forms and embolizes more rapidly, which is compatible with the more pulsatile and intense flow in arteries, whereas the venous thrombus appears and disappears more gradually.
|
Figure 5 shows a progressive shortening of closure time, when applying the PFA-100 test to blood taken from animals instilled with 50 µg of DEPs. The shortening, which reflects platelet activation, was significant at 30 minutes and was even more pronounced at 60 minutes. Platelet counts in blood were not affected.
|
Adding DEPs to untreated hamster blood also caused platelet activation, as reflected by significant dose-dependent shortenings of the PFA-100 closure times (Figure 6).
|
| Discussion |
|---|
|
|
|---|
Urban air pollution consists of a complex mixture of gaseous and particulate agents. Although gaseous pollutants, such as ozone, play an important role, respirable particles constitute the unifying element in most studies of the adverse health effects of urban air pollution.1,20 PM2.5 were consistently associated with increased cardiovascular mortality1,2 and morbidity21 in numerous American and European cities. However, the biological mechanisms underlying these associations remain unknown.5,22
Currently, it is well recognized that thrombosis underlies most acute complications of atherosclerosis, such as acute myocardial infarction.12 Recently, it has been shown that exposure to PM2.5 for as little as 2 hours increases the risk of myocardial infarction.6 In the present study, we have therefore directly addressed the question whether pollutant particles such as DEPs, which are a major contributor to urban ambient PM2.5, have an impact on this endpoint by studying thrombosis shortly after exposure to these particles. To this end, we used a recently established and validated model of acute thrombosis in the hamster.18 This photochemical injury model causes mild damage to endothelial cells and leads to the development of platelet-rich thrombi, which resemble clinical thrombi by electron microscopic analysis. This model is based on the photodynamic generation of singlet oxygen from systemically injected Rose Bengal after excitation with green light of the blood vessel. Peroxidative damage to the endothelial membrane provides the initial stimulus for platelet adhesion and thrombus formation.23,24
The time point investigated here (1 hour) is shorter than the 6 hours9 or 20 to 24 hours25,26 in other studies of the acute effects of particles, but it may well be particularly relevant for understanding pollutant-promoted myocardial infarction.6 The choice of 1 hour was based on our recent work that showed that UFPs diffuse rapidly (within minutes) from the lungs into the systemic circulation in hamster14 and in humans.15
Most of the worlds megacities have very high concentrations of particulates in ambient air, with annual averages of 200 to 600 µg/m3, and peak concentrations frequently exceed 1000 µg/m3.27 For an adult, assuming a total inhaled air volume of 20 m3 over 24 hours, >20 000 µg of particles can be inhaled during peaks of particulate air pollution. Consequently, for a hamster of 100 g, this would correspond to >30 µg. Therefore, the range of particle doses investigated here is probably relevant.
The intratracheal instillation of a bolus of particles could be criticized as being nonphysiological, but this method of delivery has been shown to be a convenient and valid, though admittedly not perfect, mode of administration of foreign compounds into the airways.28 Advantages of instillation are that the actual dose delivered to the lungs of each animal can be established accurately and that the technique is simpler than inhalation, thus permitting the introduction of a range of doses to the lung in a short time.28 Disadvantages include the essentially nonphysiological nature and the administration as a bolus as opposed to a period of several hours. The consequence of the latter on our findings remains to be established using exposure by inhalation.
Effects of DEPs on Lung Inflammation
Pulmonary inflammation within 1 hour of DEP exposure has not, to our knowledge, been reported previously. Our data show that DEPs cause a neutrophil influx in the alveoli and an increase in total protein, reflecting increased epithelial permeability.29 We have recently made similar observations after intratracheal instillation of positively charged polystyrene UFPs.17 Analogous findings have been reported in rats 6 hours after intratracheal instillation of ultrafine carbon black particles.30 In humans, Salvi et al9 found an increase in the number of neutrophils in the bronchial submucosa and epithelium 6 hours after exposure to DEPs for 1 hour. We did not find changes in LDH, but increased LDH activity, suggestive of cytolysis, has been described in the BAL of rats 24 hours after intratracheal instillation of DEPs.31 Boland et al,11 using a human bronchial epithelial cell line, have shown an effect on LDH activity at 48 hours but not at 24 hours. Histamine, an endogenous mediator of many (patho)physiological processes, is synthesized and released by mast cells in the airway wall and by circulating and infiltrating basophils. Histamine is able to modulate the cytokine network32 and to upregulate P-selectin on endothelial cells.33 Our data showing that DEPs cause a dose-related release of histamine in BAL corroborate findings of Salvi et al,9 who have shown an increase in mast cell numbers in the submucosa and elevated BAL histamine levels 6 hours after exposure to DEPs in humans. Moreover, DEPs have recently been demonstrated to directly degranulate mast cells and to increase histamine levels and symptom severity in humans.34
Effects of DEPs on Thrombosis
We found that intratracheal instillation of DEPs promotes femoral venous thrombosis in a dose-dependent manner, already starting at a dose of 5 µg per animal. We did most of our experiments with femoral vein because a more stable thrombus is produced in conditions of low blood flow encountered in veins. However, we showed that thrombosis is also enhanced in femoral artery. Many epidemiological studies1,36,13,35 have shown associations between pollution and cardiovascular morbidity and mortality, which are mainly driven by thrombotic events in arteries. There is little information regarding deep venous thrombosis or pulmonary emboli, although one study13 reported an association with the occurrence of "embolism and thrombosis." However, the relevance of our vascular thrombosis model does not depend primarily on the type of vessel that is used, but on the fact that a platelet-rich thrombus is produced in a (photochemically) injured vessel.18,23,24
The prothrombotic effects of DEPs corroborate our observations that intratracheal instillation of positively charged polystyrene particles (60 nm), taken as a model for UFPs, caused up to a 5-fold enhancement of thrombus formation in the same model.16 We attributed this rapid effect to the passage of particles into the circulation.17 Because electron microscopy of our DEPs showed a substantial fraction of small aggregates of particles only 20 to 50 nm in diameter, it seems reasonable to postulate passage of these DEPs into the systemic circulation as we have demonstrated to occur for UFPs in hamsters and in humans.14,15 Others have also found that the primary particles in diesel aggregates range from 10 to 40 nm.36 Xiong and Friedlander7 reported that the primary particle size of atmospheric aggregates emitted from combustion processes such as diesel engines ranges from 6 to 100 nm.
Our model of thrombosis depends on platelet activation and aggregation.18 Accordingly, in vivo platelet activation, as assessed ex vivo by the platelet function analyzer,19 was apparent 30 minutes after instillation of DEPs. The addition of DEPs to hamster blood in vitro caused platelet activation within 5 minutes with as little as 0.5 µg of DEPs/mL, which is a concentration that can presumably be achieved in the circulation after intratracheal instillation of 50 µg per hamster.14 All these data suggest that DEPs are prothrombotic through particle-induced platelet activation. It remains to be established which constituents are responsible for the effect and what mechanism is involved.
Our data provide novel evidence that, within an hour after their deposition in the lungs, DEPs cause pulmonary inflammation and aggravate arterial and venous thrombosis, findings we could substantiate by in vivo, ex vivo, and in vitro observations. Our findings provide a plausible explanation for the acute increases in cardiovascular morbidity and mortality caused by air pollution.
| Acknowledgments |
|---|
Received September 19, 2002; revision received November 21, 2002; accepted November 25, 2002.
| References |
|---|
|
|
|---|
2. Pope CAIII, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002; 287: 11321141.
3. Pope CAIII, Verrier RL, Lovett EG, et al. Heart rate variability associated with particulate air pollution. Am Heart J. 1999; 138 (5 pt 1): 890899.[CrossRef][Medline] [Order article via Infotrieve]
4. Gold DR, Litonjua A, Schwartz J, et al. Ambient pollution and heart rate variability. Circulation. 2000; 101: 12671273.
5. Ware JH. Particulate air pollution and mortality: clearing the air. N Engl J Med. 2000; 343: 17981799.
6. Peters A, Dockery DW, Muller JE, et al. Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001; 103: 28102815.
7. Xiong C, Friedlander SK. Morphological properties of atmospheric aerosol aggregates. Proc Natl Acad Sci U S A. 2001; 98: 1185111856.
8. Don Porto CA, Hoet PH, Verschaeve L, et al. Genotoxic effects of carbon black particles, diesel exhaust particles, and urban air particulates and their extracts on a human alveolar epithelial cell line (A549) and a human monocytic cell line (THP-1). Environ Mol Mutagen. 2001; 37: 155163.[CrossRef][Medline] [Order article via Infotrieve]
9. Salvi S, Blomberg A, Rudell B, et al. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med. 1999; 159: 702709.
10. Salvi SS, Nordenhall C, Blomberg A, et al. Acute exposure to diesel exhaust increases IL-8 and GRO-
production in healthy human airways. Am J Respir Crit Care Med. 2000; 161 (2 pt 1): 550557.
11. Boland S, Baeza-Squiban A, Fournier T, et al. Diesel exhaust particles are taken up by human airway epithelial cells in vitro and alter cytokine production. Am J Physiol. 1999; 276 (4 pt 1): L604L613.[Medline] [Order article via Infotrieve]
12. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001; 104: 365372.
13. Hoek G, Brunekreef B, Fischer P, et al. The association between air pollution and heart failure, arrhythmia, embolism, thrombosis, and other cardiovascular causes of death in a time series study. Epidemiology. 2001; 12: 355357.[CrossRef][Medline] [Order article via Infotrieve]
14. Nemmar A, Vanbilloen H, Hoylaerts MF, et al. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med. 2001; 164: 16651668.
15. Nemmar A, Hoet PH, Vanquickenborne B, et al. Passage of inhaled particles into the blood circulation in humans. Circulation. 2002; 105: 411414.
16. Nemmar A, Hoylaerts MF, Hoet PHM, et al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med. 2002; 166: 9981004.
17. Nemmar A, Hoylaerts M, Hoet PH, et al. Size effect of intratracheally instilled ultrafine particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol. 2002; 186: 3845.
18. Kawasaki T, Kaida T, Arnout J, et al. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic. Thromb Haemost. 1999; 81: 306311.[Medline] [Order article via Infotrieve]
19. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzerPFA-100. Semin Thromb Hemost. 1995; 21 (suppl 2): 106112.[Medline] [Order article via Infotrieve]
20. Schwartz J. Air pollution and hospital admissions for cardiovascular disease in Tucson. Epidemiology. 1997; 8: 371377.[CrossRef][Medline] [Order article via Infotrieve]
21. Schwartz J. Air pollution and hospital admissions for heart disease in eight U. S. counties. Epidemiology. 1999; 10: 1722.[CrossRef][Medline] [Order article via Infotrieve]
22. Yeates DB, Mauderly JL. Inhaled environmental/occupational irritants and allergens: mechanisms of cardiovascular and systemic responses: introduction. Environ Health Perspect. 2001; 109 (suppl 4): 479481.[Medline] [Order article via Infotrieve]
23. Stockmans F, Stassen JM, Vermylen J, et al. A technique to investigate mural thrombus formation in small arteries and veins, I: comparative morphometric and histological analysis. Ann Plast Surg. 1997; 38: 5662.[CrossRef][Medline] [Order article via Infotrieve]
24. Stockmans F, Stassen JM, Vermylen J, et al. A technique to investigate microvascular mural thrombus formation in arteries and veins, II: effects of aspirin, heparin, r-hirudin, and G-4120. Ann Plast Surg. 1997; 38: 6368.[CrossRef][Medline] [Order article via Infotrieve]
25. Brown DM, Stone V, Findlay P, et al. Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup Environ Med. 2000; 57: 685691.
26. Nemmar A, Delaunois A, Nemery B, et al. Inflammatory effect of intratracheal instillation of ultrafine particles in the rabbit: role of C-fiber and mast cells. Toxicol Appl Pharmacol. 1999; 160: 250261.[CrossRef][Medline] [Order article via Infotrieve]
27. UN Environment Program and World Health Organization. Air Pollution in the Worlds Megacities: A Report from the UN Environment Programme and WHO Environment. New York, NY: United Nations, 1994; 36: 537.
28. Driscoll KE, Costa DL, Hatch G, et al. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci. 2000; 55: 2435.
29. Henderson RF, Benson JM, Hahn FF, et al. New approaches for the evaluation of pulmonary toxicity: bronchoalveolar lavage fluid analysis. Fundam Appl Toxicol. 1985; 5: 451458.[CrossRef][Medline] [Order article via Infotrieve]
30. Li XY, Gilmour PS, Donaldson K, et al. In vivo and in vitro proinflammatory effects of particulate air pollution (PM10). Environ Health Perspect. 1997; 105 (suppl 5): 12791283.[CrossRef][Medline] [Order article via Infotrieve]
31. Madden MC, Richards JH, Dailey LA, et al. Effect of ozone on diesel exhaust particle toxicity in rat lung. Toxicol Appl Pharmacol. 2000; 168: 140148.[CrossRef][Medline] [Order article via Infotrieve]
32. Sirois J, Menard G, Moses AS, et al. Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: stimulation of IL-10 production. J Immunol. 2000; 164: 29642970.
33. Geng JG, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature. 1990; 343: 757760.[CrossRef][Medline] [Order article via Infotrieve]
34. Diaz-Sanchez D, Penichet-Garcia M, Saxon A. Diesel exhaust particles directly induce activated mast cells to degranulate and increase histamine levels and symptom severity. J Allergy Clin Immunol. 2000; 106: 11401146.[CrossRef][Medline] [Order article via Infotrieve]
35. Pope CAIII, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002; 287: 11321141.
36. Shi JP, Mark D, Harrison RM. Characterization of particles from a current technology heavy-duty diesel engine. Environ Sci Technol. 2000; 34: 748755.[CrossRef]
This article has been cited by other articles:
![]() |
A. Nemmar, S. Al-Salam, S. Zia, J. Yasin, I. Al Husseni, and B. H. Ali Diesel Exhaust Particles in the Lung Aggravate Experimental Acute Renal Failure Toxicol. Sci., January 1, 2010; 113(1): 267 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Lucking, M. Lundback, N. L. Mills, D. Faratian, S. L. Barath, J. Pourazar, F. R. Cassee, K. Donaldson, N. A. Boon, J. J. Badimon, et al. Diesel exhaust inhalation increases thrombus formation in man Eur. Heart J., December 2, 2008; 29(24): 3043 - 3051. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. Simkhovich, M. T. Kleinman, and R. A. Kloner Air Pollution and Cardiovascular Injury: Epidemiology, Toxicology, and Mechanisms J. Am. Coll. Cardiol., August 26, 2008; 52(9): 719 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Tankersley, H. C. Champion, E. Takimoto, K. Gabrielson, D. Bedja, V. Misra, H. El-Haddad, R. Rabold, and W. Mitzner Exposure to inhaled particulate matter impairs cardiac function in senescent mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R252 - R263. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nemmar, K. Melghit, and B. H. Ali The Acute Proinflammatory and Prothrombotic Effects of Pulmonary Exposure to Rutile TiO2 Nanorods in Rats Exp Biol Med, May 1, 2008; 233(5): 610 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Mills, G. Oberdorster, and D. E. Newby Reducing Exposure to Airborne Particles: A Novel Strategy to Improve Cardiovascular Health Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 366 - 367. [Full Text] [PDF] |
||||
![]() |
K. Yatera, J. Hsieh, J. C. Hogg, E. Tranfield, H. Suzuki, C.-H. Shih, A. R. Behzad, R. Vincent, and S. F. van Eeden Particulate matter air pollution exposure promotes recruitment of monocytes into atherosclerotic plaques Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H944 - H953. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Mills, H. Tornqvist, M. C. Gonzalez, E. Vink, S. D. Robinson, S. Soderberg, N. A. Boon, K. Donaldson, T. Sandstrom, A. Blomberg, et al. Ischemic and Thrombotic Effects of Dilute Diesel-Exhaust Inhalation in Men with Coronary Heart Disease N. Engl. J. Med., September 13, 2007; 357(11): 1075 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Kaufman Air Pollution and Mortality: Are We Closer to Understanding the How? Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 325 - 326. [Full Text] [PDF] |
||||
![]() |
K. Toren, I. A Bergdahl, T. Nilsson, and B. Jarvholm Occupational exposure to particulate air pollution and mortality due to ischaemic heart disease and cerebrovascular disease Occup. Environ. Med., August 1, 2007; 64(8): 515 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shimada, N. Kawamura, M. Okajima, T. Kaewamatawong, H. Inoue, and T. Morita Translocation Pathway of the Intratracheally Instilled Ultrafine Particles from the Lung into the Blood Circulation in the Mouse Toxicol Pathol, December 1, 2006; 34(7): 949 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Inoue, H. Takano, M. Sakurai, T. Oda, H. Tamura, R. Yanagisawa, A. Shimada, and T. Yoshikawa Pulmonary Exposure to Diesel Exhaust Particles Enhances Coagulatory Disturbance with Endothelial Damage and Systemic Inflammation Related to Lung Inflammation Exp Biol Med, November 1, 2006; 231(10): 1626 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhatnagar Environmental Cardiology: Studying Mechanistic Links Between Pollution and Heart Disease Circ. Res., September 29, 2006; 99(7): 692 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nawrot, A. Nemmar, and B. Nemery Update in environmental and occupational medicine 2005. Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 948 - 952. [Full Text] [PDF] |
||||
![]() |
Q. Sun, A. Wang, X. Jin, A. Natanzon, D. Duquaine, R. D. Brook, J.-G. S. Aguinaldo, Z. A. Fayad, V. Fuster, M. Lippmann, et al. Long-term Air Pollution Exposure and Acceleration of Atherosclerosis and Vascular Inflammation in an Animal Model JAMA, December 21, 2005; 294(23): 3003 - 3010. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Forastiere, M. Stafoggia, S. Picciotto, T. Bellander, D. D'Ippoliti, T. Lanki, S. von Klot, F. Nyberg, P. Paatero, A. Peters, et al. A Case-Crossover Analysis of Out-of-Hospital Coronary Deaths and Air Pollution in Rome, Italy Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1549 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wellenius, J. Schwartz, and M. A. Mittleman Air Pollution and Hospital Admissions for Ischemic and Hemorrhagic Stroke Among Medicare Beneficiaries Stroke, December 1, 2005; 36(12): 2549 - 2553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajagopalan, Q. Sun, and L. C. Chen Particulate Pollution and Endothelial Function: Deja Vu All Over Again in the Air Circulation, June 7, 2005; 111(22): 2869 - 2871. [Full Text] [PDF] |
||||
![]() |
A. Nemmar, B. Nemery, P. H. M. Hoet, N. Van Rooijen, and M. F. Hoylaerts Silica Particles Enhance Peripheral Thrombosis: Key Role of Lung Macrophage-Neutrophil Cross-Talk Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 872 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. van Eeden, A. Yeung, K. Quinlam, and J. C. Hogg Systemic Response to Ambient Particulate Matter: Relevance to Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 61 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.E. Sharman, J.R. Cockcroft, and J.S. Coombes Cardiovascular implications of exposure to traffic air pollution during exercise QJM, October 1, 2004; 97(10): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nemmar, P. H.M. Hoet, J. Vermylen, B. Nemery, and M. F. Hoylaerts Pharmacological Stabilization of Mast Cells Abrogates Late Thrombotic Events Induced by Diesel Exhaust Particles in Hamsters Circulation, September 21, 2004; 110(12): 1670 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Brook, B. Franklin, W. Cascio, Y. Hong, G. Howard, M. Lipsett, R. Luepker, M. Mittleman, J. Samet, S. C. Smith Jr, et al. Air Pollution and Cardiovascular Disease: A Statement for Healthcare Professionals From the Expert Panel on Population and Prevention Science of the American Heart Association Circulation, June 1, 2004; 109(21): 2655 - 2671. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Khandoga, A. Stampfl, S. Takenaka, H. Schulz, R. Radykewicz, W. Kreyling, and F. Krombach Ultrafine Particles Exert Prothrombotic but Not Inflammatory Effects on the Hepatic Microcirculation in Healthy Mice In Vivo Circulation, March 16, 2004; 109(10): 1320 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Johnson Jr Relative Effects of Air Pollution on Lungs and Heart Circulation, January 6, 2004; 109(1): 5 - 7. [Full Text] [PDF] |
||||
![]() |
A. Nemmar, B. Nemery, P. H. M. Hoet, J. Vermylen, and M. F. Hoylaerts Pulmonary Inflammation and Thrombogenicity Caused by Diesel Particles in Hamsters: Role of Histamine Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1366 - 1372. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |